Navigation Links
Abattis Participates In Project On A Whole Plant Therapeutic For Treating Malaria And Other Diseases And Reducing Drug Resistance
Date:3/8/2013

VANCOUVER, British Columbia, March 8, 2013 /PRNewswire/ -- Abattis Bioceuticals Corp. ("Abattis" or the "Company") (CNSX: FLU) (OTC: ATTBF), is pleased to announce its participation in a research project led by Pamela Weathers , Professor of Biology and Biotechnology at Worcester Polytechnic Institute (WPI) in Worcester, Mass. that is investigating a whole plant therapeutic for treating malaria and other diseases, one that may also reduce drug resistance.

Mr. Mike Withrow , Chief Executive Officer on behalf of the Company, stated, "We are very excited to have the opportunity to explore a highly innovative approach to treat those diseases that are responsive to artemisinin. Our vertical hydroponic system and extraction methods could assist Professor Weathers' efforts in cultivating Artemisia annua for further developing this therapeutic technology."

Artemisinin, derived from the sweet wormwood plant, Artemisia annua, is an effective treatment for malaria, but it is expensive to produce (particularly when combined with other antimalarial medications to make it less prone to resistance) and is frequently in short supply. Research by the Weathers team has shown that powdered dried leaves from the plant may be a far more effective antimalarial treatment than purified artemisinin and may greatly reduce the risk of resistance.

"Working with Abattis provides an exciting opportunity to move this important medicinal plant into commercial utility for broader public use. I am looking forward to what I anticipate will be a very fruitful relationship," said Professor Weathers.

Professor Weathers received her Ph.D. at the Michigan State University Plant Research Lab in 1974. She has received numerous awards for her research and many international speaking invitations. She is a Fellow of the Society for In Vitro Biology. Her work on A. annua spans over 20 years and her team was the first to genetically transform the plant. She has several patents and about 100 peer-reviewed publications, of which more than a third are on A. annua or artemisinin. She has supervised many undergraduate and graduate student theses on many aspects of plant biotechnology including bioreactor development for in vitro plant propagation.

About Abattis Bioceuticals Corp.
Abattis Bioceuticals Corp. is a specialty biotechnology company with capabilities through its wholly owned subsidiaries of producing, licensing and marketing proprietary ingredients and products containing standardized phytochemicals for sale in Pharmaceutical, Nutraceutical, Cosmetic and Animal Nutrition markets. The company also has a deep pipeline of proprietary products ready for sale in high growth areas of Functional Foods and Supplements business. For more information, visit the Company's website at www.abattis.com.

About Worcester Polytechnic Institute
Founded in 1865 in Worcester, Mass., WPI was one of the nation's first engineering and technology universities. Its 14 academic departments offer more than 50 undergraduate and graduate degree programs in science, engineering, technology, business, the social sciences, and the humanities and arts, leading to bachelor's, master's and doctoral degrees. WPI's talented faculty work with students on interdisciplinary research that seeks solutions to important and socially relevant problems in fields as diverse as the life sciences and bioengineering, energy, information security, materials processing, and robotics. Students also have the opportunity to make a difference to communities and organizations around the world through the university's innovative Global Perspective Program. There are more than 30 WPI project centers throughout North America and Central America, Africa, Australia, Asia, and Europe.

ON BEHALF OF THE BOARD

" Michael Withrow "       
Michael Withrow , President & CEO

Neither the CNSX Exchange nor its regulations services accepts responsibility
for the adequacy or accuracy of this release.

Contact:
Mr. Mike Withrow
778-896-6536


'/>"/>
SOURCE Abattis Bioceuticals Corp.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. DATATRAK Participates in March Industry Events
2. Acceliant Participates as Platinum Sponsor at the SCDM Annual Conference in Los Angeles
3. FAME 2 Published in the New England Journal of Medicine, Volcano participates in the $84M NIH-Sponsored ISCHEMIA Trial
4. PRA Participates in Landmark Alzheimers Prevention Clinical Trial
5. Misonix Participates In Cleveland Spine Review
6. BlackStratus participates in Joint FDA-ISPE CGMP Conference
7. University of Michigans Wolverine Venture Fund Participates in $25 Million Series D Investment in Sonitus Medical
8. Nutrastar International Completes Multi-Year Production Expansion Project Bringing Cordyceps Capacity to 100 Tons
9. CPhI in Partnership With PMI India Announces Pharma Project Management Conference
10. Physicians Capital Investments Receives "Outstanding Development Award" for Sandy, Oregon Project
11. Natalie Douglas, CEO of Idis, Joins Global Genes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... -- - Cardiac Marker Diagnostic Testing ... Cancer Therapy. - European Point of Care Diagnostic ... - Key Diagnostic Testing Markets. - Molecular Diagnostics ... Testing. - Molecular Diagnostics in Infectious Disease Testing. ... Products World Markets. - Point of Care Diagnostic ...
(Date:2/11/2016)... Feb. 11, 2016 Stem cells are primitive ... by self-renewal and the capacity to differentiate into mature ... discovery, as the first mouse embryonic stem cells were ... until 1995 that the first culturing of embryonic stem ... were not produced until 2006 As a result of ...
(Date:2/11/2016)... 11, 2016 Laboratory glassware and ... laboratories. These may range from microscope slides to large ... made from borosilicate glass because of its low weight ... other hand, started gaining popularity over the past decade ... replace glass with plastic in several applications due to ...
Breaking Medicine Technology:
(Date:2/13/2016)... (PRWEB) , ... February 13, 2016 , ... ... School of Nursing with an in-kind gift of a VeinViewer® Vision vein ... as they learn how to start an IV and draw blood, combining technology ...
(Date:2/13/2016)... ... February 13, 2016 , ... DDi ... Management Solution Providers list for its expertise in eClinical Solutions. DDi has built ... serve the technology needs of global clients. DDi provides smarter technology for Clinical ...
(Date:2/12/2016)... ... February 12, 2016 , ... The law firm of Morrow, Morrow, Ryan & ... purpose of these scholarships is to encourage applicants to pursue a degree in their ... these two parishes. , “We have available jobs in St. Landry and Evangeline ...
(Date:2/12/2016)... ... February 12, 2016 , ... CDRH Enforcement Trends: , Back to the Future , ... , As Winston Churchill said, “Those who don’t learn from history are doomed to ... expect when they come knocking this year. But that takes time. , Take a ...
(Date:2/12/2016)... , ... February 12, 2016 , ... As a former ... schedule, a demanding job, and no time to decompress, Rabinowitz found herself drawn to ... to meditation for its impact on her life, implementing a 20-minute-per-day meditation practice with ...
Breaking Medicine News(10 mins):